Wordt geladen...
Cholinesterase inhibitors in patients with diabetes mellitus and dementia: an open-cohort study of ~23 000 patients from the Swedish Dementia Registry
OBJECTIVE: Cholinesterase inhibitors (ChEIs) and memantine are the only approved pharmacological treatments for Alzheimer’s disease (AD). Recent literature suggests reductions in cardiovascular burden and risk of stroke in ChEI users. However, the clinical effectiveness of these drugs in patients wi...
Bewaard in:
| Gepubliceerd in: | BMJ Open Diabetes Res Care |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BMJ Publishing Group
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7039592/ https://ncbi.nlm.nih.gov/pubmed/31958305 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjdrc-2019-000833 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|